Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKesson
Boehringer Ingelheim
QuintilesIMS
Moodys
Daiichi Sankyo
Healthtrust
Covington
Baxter

Generated: April 27, 2018

DrugPatentWatch Database Preview

HUMATROPE Drug Profile

« Back to Dashboard

Which patents cover Humatrope, and what generic alternatives are available?

Humatrope is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in HUMATROPE is somatropin recombinant. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.

US Patents and Regulatory Information for HUMATROPE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-001 Jun 23, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-006 Feb 4, 1999 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-004 Mar 8, 1987 BX RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-005 Feb 4, 1999 BX RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for HUMATROPE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-006 Feb 4, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-007 Feb 4, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-004 Mar 8, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-005 Feb 4, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKesson
McKinsey
AstraZeneca
Accenture
Harvard Business School
Colorcon
Daiichi Sankyo
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.